B C Supplementary Figure 1 Control X0 Control X9  -HBx (mAb)  -HBx (rabbit serum) ABCEFD 1 58 85 120 154 aa ABCEF X0 X9 (  D) A 100 90 80 70 60 50 40.

Slides:



Advertisements
Similar presentations
Supplemental Figure 1 a % pulldown from input LNCaP/scrambled-siRNA Figure 1 A, ChIP analysis of AR and PHB binding to the PSA promoter in the LNCaP/scrambled-siRNA.
Advertisements

WT KO A B Suppl. Fig 1 Supplemental Figure 1. The expression of CYLD in liver. (A) Immunohistochemical analysis of CYLD in liver tissue of adult wildtype.
Supplementary Figure 1. Supplementary Figure 2 Suppl. Fig. 1. The promoter of miR-155 encoding Bic gene contains two putative NF-  B binding sites.
Cancer Detection and Diagnosis Early Cancer May Not Have Any symptoms Pap Test Mammograms Blood tests Prostate-specific antigen (PSA) Carcinoembryonic.
Transcriptional targets shared by estrogen receptor ‐ related receptors (ERRs) and estrogen receptor (ER) α, but not by ERβ by Jean ‐ Marc Vanacker, Katarina.
FINAL IN FOWLER A103B TUESDAY, JUNE 14 11:30 AM -- 2:30 PM POINTS FROM MIDTERM QUESTIONS POINTS FROM FINAL QUESTIONS.
CREB Binding Protein Recruitment to the Transcription Complex Requires Growth Factor–Dependent Phosphorylation of Its GF Box  Kerstin Zanger, Sally Radovick,
Fig. 4. miR-326, miR-330, and miR-3099 bound to the GFAP 3'-UTR and regulated GFAP expression. (A) Schematic diagram of potential binding sequence (seed.
Are At1g08810 and At3g50060 Important to Arabidopsis Seed Development?
A B C D ** CpG-free Luc -7,200 -5,900 e2piNOS-luc -4,900 e1piNOS-luc
a GM DM1 DM3 DM5 DM7 b MHC MHC +DAPI GM DM4
Up-Regulation of Activating Transcription Factor-5 Suppresses SAP Expression to Activate T Cells in Hemophagocytic Syndrome Associated with Epstein-Barr.
A B C D Rao et al., 2012; Supplementary Figure S1 p = 0.03 p = NS
Fig. 1. Effects of MD-2 promoter SNPs on transcription activity
Chap. 19 Problem 1 Passage through the cell cycle is unidirectional and irreversible due to the degradation of critical regulators by proteasome complexes.
by Toshibumi Shimokawa, and Chisei Ra
by Hong Hao, Huiling Qi, and Manohar Ratnam
Volume 11, Issue 6, Pages (June 2003)
Wild‐type p53 binds and represses Rad51 promoter.
Transcriptional activity of the exogenous cyclin B1 promoter is high in the G2/M phases of the cell cycle. Transcriptional activity of the exogenous cyclin.
Functional properties of pRb.
Control of IL‐6 synthesis by ζPKC and RelA Ser311 phosphorylation.
by Wu-Guo Deng, Ying Zhu, and Kenneth K. Wu
TIEG1 Represses Smad7-Mediated Activation of TGF-β1/Smad Signaling in Keloid Pathogenesis  Zhi-Cheng Hu, Fen Shi, Peng Liu, Jian Zhang, Dong Guo, Xiao-Ling.
EP4 promoter activity is induced by sulindac sulfide in T98G cells.
by Milind C. Mahajan, and Sherman M. Weissman
Recruitment of Ataxia-Telangiectasia Mutated to the p21waf1 Promoter by ZBP-89 Plays a Role in Mucosal Protection  Longchuan Bai, John Y. Kao, David J.
Gel Retardation.
The interferon regulatory factor ICSBP/IRF-8 in combination with PU
Laminin γ2 Mediates Wnt5a-Induced Invasion of Gastric Cancer Cells
M. Ushita, T. Saito, T. Ikeda, F. Yano, A. Higashikawa, N. Ogata, U
SP1 was a downstream target of miR-150-3p
Volume 21, Issue 1, Pages (July 2004)
Sequencing at 10,000x using Illumina paired reads
ATF5 transactivates Egr-1 via the ATF5CON sites in the Egr-1 promoter.
Polina Iakova, Samir S Awad, Nikolai A Timchenko  Cell 
Volume 137, Issue 1, Pages (July 2009)
SUMO Promotes HDAC-Mediated Transcriptional Repression
Volume 129, Issue 5, Pages (November 2005)
Histone Acetylation Regulates the Time of Replication Origin Firing
Consequences of reducing SF3B2 expression.
Volume 10, Issue 7, Pages (July 2017)
Supplementary Figure 1 IP: IgG HA 3HA-E2F1: cIAP1: wt K
Volume 10, Issue 6, Pages (December 2006)
Roth et al, Supplementary Figure 1
Volume 98, Issue 6, Pages (September 1999)
The Basis for IL-2-Induced IL-2 Receptor α Chain Gene Regulation
DNA Replication and Oncogene-Induced Replicative Stress
Volume 142, Issue 4, Pages e4 (April 2012)
Volume 126, Issue 4, Pages (April 2004)
A B Supplementary Figure S1 PC3 cells Vehicle 3β-Adiol
miR-330-5p Targets Tyrosinase and Induces Depigmentation
Xiang Han, Hao Yu, Rongrong Yuan, Yan Yang, Fengying An, Genji Qin
Volume 9, Issue 9, Pages (May 1999)
Volume 10, Issue 9, Pages (May 2000)
Verification of NEUROD2 binding to the conserved element within Stim1 intron 2. Verification of NEUROD2 binding to the conserved element within Stim1 intron.
Volume 25, Issue 10, Pages (October 2017)
Defining the Regulatory Elements in the Proximal Promoter of ΔNp63 in Keratinocytes: Potential Roles for Sp1/Sp3, NF-Y, and p63  Rose-Anne Romano, Barbara.
TP53 western blot of primary cultured tail cells from both wild-type (WT) and Tp53Δ11/Δ11 (−/−) rats. TP53 western blot of primary cultured tail cells.
Transcriptional Regulation of AKT Activation by E2F
Cell cycle release after M phase arrest (h)
Functional promoter activity of the human COX-2 gene in HMCs
Volume 72, Issue 2, Pages (July 2007)
Boyan Bonev, Peter Stanley, Nancy Papalopulu  Cell Reports 
Acne Inversa Caused by Missense Mutations in NCSTN Is Not Fully Compatible with Impairments in Notch Signaling  Xulun Zhang, Sangram S. Sisodia  Journal.
The Vitamin D Response Element of the Involucrin Gene Mediates its Regulation by 1,25-Dihydroxyvitamin D3  Daniel D. Bikle, Dean Ng, Yuko Oda, Karen Hanley,
Figure 2. p62−/−MEF cells enhance the activation of NF-κB induced by TLR4. (A) Wild-type (WT) p62+/+MEF and p62−/−MEF cells were transfected with pBIIx-luc.
Recruitment of Ataxia-Telangiectasia Mutated to the p21waf1 Promoter by ZBP-89 Plays a Role in Mucosal Protection  Longchuan Bai, John Y. Kao, David J.
Targeting DCLK1 by miRNA-137.
Fig. 3. PTEN a target of miR-182-5p
Presentation transcript:

B C Supplementary Figure 1 Control X0 Control X9  -HBx (mAb)  -HBx (rabbit serum) ABCEFD aa ABCEF X0 X9 (  D) A Control X0 X9 Control X0 X9 Control X0 X9 Control X0 X9 Control X0 X9 Control X0 X9 Control X0 X9 Control X0 X9 Post Double Thymidine Block (h) Cells (%)

Cyclin A Binding (68-108) DNA Binding ( ) DP-1 Binding ( ) Transactivation Domain ( ) Rb binding E2F1-WT E2F1 (1-374) Transactivation Domain mutant Wild-type C B Normalized luciferase units Control X0 pGL3 CDC6 WT CDC6-SM1 # # A E2F1 CCAAT NF  AP CDC6 WT Wild type E2F1 binding site TTTGGCGC E2F1 Mutant E2F1 binding site TTTAACGC CDC6-SM1 E2F Luciferase CDC6 promoter [-1534, +225] Supplementary Figure 2

E2F E2F pGL3-E2F1 WT pGL3-E2F1 Mut Luciferase E2F1 CCAAT Sp CCAAT Sp E2F1 promoter [-728, +127] Supplementary Figure 3

Relative abundance of CDC6 on human  -globin origin of replication (arbitrary unit) Serum Stimulation (h) Relative abundance of CDC6 on human  -globulin locus (arbitrary unit) Serum Stimulation (h) ChIP  -CDC6 Control Input Serum Stimulation Control X0 X9 A 3h 7h Control ChIP Input Serum Stimulation Control X0 X9 B 3h 7h  -CDC6 Human  -globin origin  -globulin non-origin locus Supplementary Figure 4